BNTC icon

Benitec Biopharma
BNTC

Overview Fund Activity

25 hedge funds and large institutions have $2.09M invested in Benitec Biopharma in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 6 closing their positions.

Holders
25
Holders Change
–
Holders Change %
0%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
4
Reduced
6
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Morgan Stanley
1
Morgan Stanley
New York
$62.7K
2
Renaissance Technologies
2
Renaissance Technologies
New York
$64K
3
Walleye Capital
3
Walleye Capital
New York
$58.5K
4
VF
4
Virtu Financial
New York
$14K
5
TSS
5
Two Sigma Securities
New York
$9.36K

Top Sellers

1
AC
1
Armistice Capital
New York
$0
2
CH
2
CVI Holdings
Delaware
$0
3
ACM
3
Altium Capital Management
New York
$0
4
Millennium Management
4
Millennium Management
New York
$0
5
CF
5
Cantor Fitzgerald
New York
$4K
Name Market Value Shares Shares
Change 		Shares
Change %
ACM
26
Altium Capital Management
New York
– – -658,796 Closed
Millennium Management
27
Millennium Management
New York
– – -52,190 Closed
Bank of New York Mellon
28
Bank of New York Mellon
New York
– – -14,831 Closed
Simplex Trading
29
Simplex Trading
Illinois
– – -100 Closed
CG
30
Cutler Group
California
$0 1,000 – –
CFGS
31
Concourse Financial Group Securities
Alabama
– – – –
Rockefeller Capital Management
32
Rockefeller Capital Management
New York
$0 300 – –
1
2